tirzepatide uptodate FDA Grants a New Indication for Obesity Management Our Weight Management Program By

Sommige mensen hebben nauwelijks last, terwijl anderen duidelijk merken dat hun spijsvertering verandert

confirm your most recent injection date [1] [2] Duration of therapy : How long you have been taking the medication Indication for use : Whether prescribed for type 2 diabetes or weight management Gastrointestinal symptoms : Any history of nausea, vomiting, reflux, or gastroparesis Other diabetes medications : Complete list of glucose-lowering agents Recent glycemic control : A1C values and typical blood glucose ranges During the preoperative discussion, patients should ask specific questions: Should I continue or hold my medication before surgery based on my individual risk factors

The exact timing should be determined through discussion with your anaesthetist and surgical team, following your hospital's specific protocols

Ongoing support Get access to Shed Health Coaching, unlimited provider follow-ups, step-by-step health courses, and more.* Start your weight-loss journey with Wegovy Start your weight-loss journey with Wegovy Supports healthy metabolic function* Supports weight management* *This information is for educational purposes only and is not a substitute for professional medical advice

Related Article: GLP-1R Agonists for Weight Loss Novo Nordisk pioneered the use of semaglutide (Wegovy) in the treatment of obesity and received FDA approval for the treatment of obesity in adults in June 2021